{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:07:22Z","timestamp":1783102042407,"version":"3.54.6"},"reference-count":32,"publisher":"Elsevier BV","issue":"49-50","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.vaccine.2006.06.078","type":"journal-article","created":{"date-parts":[[2006,7,22]],"date-time":"2006-07-22T11:16:08Z","timestamp":1153566968000},"page":"7115-7123","source":"Crossref","is-referenced-by-count":17,"title":["The rabies peripheral challenge test: More accurate determination of vaccine potency"],"prefix":"10.1016","volume":"24","author":[{"given":"Peter S.","family":"Wunderli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Dreesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George M.","family":"Baer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2006.06.078_bib1","series-title":"Progress in Rabies Control","first-page":"602","article-title":"Potency Testing for Rabies Vaccines","author":"Blancou","year":"1989"},{"key":"10.1016\/j.vaccine.2006.06.078_bib2","unstructured":"WHO Expert Committee on Rabies. Eighth report. Geneva: World Health Organization; 1992 [WHO technical report series no. 824]."},{"key":"10.1016\/j.vaccine.2006.06.078_bib3","unstructured":"Requirements for Rabies Vaccine for Veterinary Use (requirements for biological substances no. 29, Amendment 1992). Geneva: World Health Organization; 1994 [WHO technical report no. 840]."},{"key":"10.1016\/j.vaccine.2006.06.078_bib4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0264-410X(88)90185-5","article-title":"NIH test, a problematic method for testing potency of inactivated rabies vaccine","volume":"6","author":"Barth","year":"1988","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.06.078_bib5","series-title":"Cell culture rabies vaccines and their protective effect in man","first-page":"259","article-title":"Potency test for inactivated rabies vaccine. II. NIH test in practice","author":"Aubert","year":"1981"},{"key":"10.1016\/j.vaccine.2006.06.078_bib6","first-page":"179","article-title":"Questions concerning the potency of rabies vaccine","volume":"40","author":"Crick","year":"1978","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2006.06.078_bib7","first-page":"203","article-title":"A potency test which simulates natural exposure for measuring postexposure activity","volume":"40","author":"Bijlenga","year":"1978","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2006.06.078_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0092-1157(78)80040-7","article-title":"Laboratory evaluation of the immune response to rabies vaccine","volume":"6","author":"Fitzgerald","year":"1978","journal-title":"J Biol Stand"},{"key":"10.1016\/j.vaccine.2006.06.078_bib9","series-title":"Rabies in the tropics","first-page":"312","article-title":"In vitro determination of the antigenic potency of rabies vaccine and comparison with the NIH test","author":"Vincent-Falquet","year":"1985"},{"key":"10.1016\/j.vaccine.2006.06.078_bib10","first-page":"93","article-title":"Alternatives for potency testing of veterinary vaccines: rabies vaccine as a model","volume":"64","author":"Bruckner","year":"1986","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2006.06.078_bib11","series-title":"Laboratory techniques in rabies","first-page":"279","article-title":"The NIH test for potency","author":"Seligmann","year":"1973"},{"key":"10.1016\/j.vaccine.2006.06.078_bib12","first-page":"316","article-title":"Comments on the potency testing of rabies vaccines","volume":"21","author":"Crick","year":"1974","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2006.06.078_bib13","first-page":"17","article-title":"Establishment of batch 4 of the biological reference preparation (BRP) for rabies vaccine (inactivated) for veterinary use","volume":"1","author":"Daas","year":"2004","journal-title":"Pharmeur Bio"},{"key":"10.1016\/j.vaccine.2006.06.078_bib14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1006\/biol.1996.0012","article-title":"Use of ELISA for in vitro potency test of rabies vaccines for animal use","volume":"24","author":"Gamoh","year":"1994","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2006.06.078_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0166-0934(95)01999-5","article-title":"Rabies vaccine potency control: comparison of ELISA systems for antigenicity testing","volume":"58","author":"Rooijakkers","year":"1996","journal-title":"J Virol Meth"},{"key":"10.1016\/j.vaccine.2006.06.078_bib16","first-page":"137","article-title":"Development and evaluation of alternative testing methods for the in vivo NIH potency test used for quality control of inactivated rabies vaccines","volume":"86","author":"Rooijakkers","year":"1996","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2006.06.078_bib17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/01652176.1996.9694637","article-title":"Potency of veterinary rabies vaccines in The Netherlands: a case for continued vigilance","volume":"18","author":"Rooijakkers","year":"1996","journal-title":"J Vet Q"},{"key":"10.1016\/j.vaccine.2006.06.078_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1045-1056(02)00070-2","article-title":"Inactivated rabies vaccine control and release: use of an ELISA method","volume":"31","author":"Fournier-Caruana","year":"2003","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2006.06.078_bib19","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1292\/jvms.65.685","article-title":"Establishment of a potency test by ELISA for a rabies vaccine for animal use in Japan","volume":"6","author":"Gamoh","year":"2003","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.vaccine.2006.06.078_bib20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1045-1056(05)80051-X","article-title":"Rabies vaccine standardization: international collaborative study for the characterization of the fifth international standard for rabies vaccine","volume":"20","author":"Lyng","year":"1992","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2006.06.078_bib21","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/0264-410X(91)90188-C","article-title":"The protective role of humoral neutralizing antibody in the NIH potency test for rabies vaccines","volume":"9","author":"Wunderli","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.06.078_bib22","unstructured":"Wunderli PS, Shaddock JH, Fekadu M, Miller TJ, Baer GM, Dreesen DW. In vivo elimination of immune cell populations decreases mortality from intracerebral rabies challenge. ASM general meeting, program and abstracts 79:E3; 1992."},{"key":"10.1016\/j.vaccine.2006.06.078_bib23","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2460\/ajvr.2003.64.491","article-title":"Effects of vaccine route and dosage on protection from rabies following intracerebral challenge in mice","volume":"64","author":"Wunderli","year":"2003","journal-title":"AJVR"},{"key":"10.1016\/j.vaccine.2006.06.078_bib24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2460\/ajvr.2003.64.499","article-title":"Effect of rabies virus strain heterogeneity and challenge route on the potency of inactivated rabies vaccines","volume":"64","author":"Wunderli","year":"2003","journal-title":"AJVR"},{"key":"10.1016\/j.vaccine.2006.06.078_bib25","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2460\/ajvr.1997.58.08.837","article-title":"Evaluation of an animal rabies vaccine by use of two types of potency test","volume":"58","author":"Baer","year":"1997","journal-title":"AJVR"},{"key":"10.1016\/j.vaccine.2006.06.078_bib26","series-title":"Cell culture rabies vaccines and their protective effect in man","first-page":"259","article-title":"Potency test for inactivated rabies vaccine. I. Critical study of the NIH test using a peripheral test","author":"Aubert","year":"1981"},{"key":"10.1016\/j.vaccine.2006.06.078_bib27","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/BF01941183","article-title":"Reduction in the number of mice used for potency testing of human and animal rabies vaccines","volume":"44","author":"Bruckner","year":"1988","journal-title":"Experentia"},{"key":"10.1016\/j.vaccine.2006.06.078_bib28","first-page":"535","article-title":"A rapid, reproducible test for determining rabies neutralizing antibody","volume":"48","author":"Smith","year":"1973","journal-title":"Bull World Health Organization"},{"key":"10.1016\/j.vaccine.2006.06.078_bib29","series-title":"Laboratory techniques in rabies","first-page":"73","article-title":"The fluorescent antibody test","author":"Dean","year":"1973"},{"key":"10.1016\/j.vaccine.2006.06.078_bib30","first-page":"262","article-title":"Strains of rabies virus available for preparation of sylvatic rabies vaccines with special reference to vaccines prepared in cell culture","volume":"22","author":"Rhodes","year":"1981","journal-title":"Can Vet J"},{"key":"10.1016\/j.vaccine.2006.06.078_bib31","series-title":"Laboratory techniques in rabies","first-page":"321","article-title":"Calculation of titres and their significance: A. the Spearman\u2013Karber method; B. method of Reed and Muench; C. infectivity titration based upon plaque counts","author":"Lorenz","year":"1973"},{"key":"10.1016\/j.vaccine.2006.06.078_bib32","series-title":"New generation vaccines","first-page":"85","article-title":"Immunogenicity and immunopotentiation","author":"Nossal","year":"1990"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06008188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06008188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T13:56:32Z","timestamp":1707141392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06008188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":32,"journal-issue":{"issue":"49-50","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0264410X06008188"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.06.078","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}